However, by 9-15 weeks of age p16Ink4a +/+ and +/− mice showed persistent hyperglycemia compared to their p16Ink4a −/− littermates, although even the p16Ink4a deficient mice did not show complete recovery to pre-STZ levels of glucose tolerance, survival, and weight. This evidence concerns the gene CDKN2A and Hyperglycemia.